Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy BridgeBio Pharma (BBIO) stocks in Canada
Learn how to easily invest in BridgeBio Pharma stocks.
BridgeBio Pharma is a biotechnology business based in the US. BridgeBio Pharma stocks (BBIO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $63.95 – a decrease of 10.12% over the previous week. BridgeBio Pharma employs 385 staff and has a trailing 12-month revenue of around $57 million.
How to buy shares in BridgeBio Pharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BBIO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in BridgeBio Pharma?
- Has coronavirus impacted BridgeBio Pharma shares?
- BridgeBio Pharma shares summary
- Compare share dealing platforms
- Is BridgeBio Pharma stock a buy or sell?
- BridgeBio Pharma performance over time
- BridgeBio Pharma's financials
- How volatile are BridgeBio Pharma shares?
- Does BridgeBio Pharma pay a dividend?
- Other common questions
BridgeBio Pharma stock price (NASDAQ:BBIO)Use our graph to track the performance of BBIO stocks over time.
BridgeBio Pharma shares at a glance
|Latest market close||$11.46|
|52-week range||$11.20 - $73.50|
|50-day moving average||$34.13|
|200-day moving average||$49.11|
|Wall St. target price||$27.40|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.89|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy BridgeBio Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
BridgeBio Pharma price performance over time
|1 week (2022-01-14)||-10.12%|
|1 month (2021-12-17)||N/A|
|3 months (2021-10-20)||-74.76%|
|6 months (2021-07-21)||-81.40%|
|1 year (2021-01-21)||-82.75%|
|2 years (2020-01-21)||-64.44%|
|3 years (2019-01-17)||N/A|
|5 years (2017-01-17)||N/A|
BridgeBio Pharma financials
|Revenue TTM||$57 million|
|Gross profit TTM||$8.2 million|
|Return on assets TTM||-42.63%|
|Return on equity TTM||-1789.67%|
|Market capitalisation||$1.9 billion|
TTM: trailing 12 months
BridgeBio Pharma share dividends
We're not expecting BridgeBio Pharma to pay a dividend over the next 12 months.
BridgeBio Pharma share price volatility
Over the last 12 months, BridgeBio Pharma's shares have ranged in value from as little as $11.2 up to $73.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BridgeBio Pharma's is 0.6079. This would suggest that BridgeBio Pharma's shares are less volatile than average (for this exchange).
BridgeBio Pharma overview
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include BBP-265, a small molecule stabilizer of transthyretin, or TTR, that is in an ongoing Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor which is an ongoing Phase 2 clinical trial for the treatment of achondroplasia in pediatric patients; an AAV5 gene transfer product candidate for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD; and Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, an ongoing phase 2 proof-of-concept clinical trial for Autosomal Dominant Hypocalcemia Type 1, or ADH1. The company also engages in developing products for Mendelian, genetic dermatology, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; The Regents of the University of California; Leidos Biomedical Research, Inc.
Stocks similar to BridgeBio Pharma
BridgeBio Pharma in the news
Netflix quietly admits streaming competition is eating into growth
BridgeBio Pharma : Corporate Presentation January 2022
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.